Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: Impact of Selenium on Methotrexate Induced Spermatotoxicity; A Comparative Study [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial from Ain Shams University evaluating whether selenium supplementation can mitigate methotrexate-induced spermatotoxic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Selenium (selenium)

Snippet

Sponsor: Ain Shams University | Conditions: Methotrexate Spermatotoxicity | Phase 1, Phase 2 | Status: COMPLETED